RCAS1 decidual immunoreactivity during stillbirth: Immune cell presence and activity

American Journal of Reproductive Immunology

Volumn 60, Issue 6, 2008, Pages 513-522

  Galazka, Krystyna ^a   Wicherek, Lukasz ^a   Sikora, Jerzy ^b   Czekierdowski, Artur ^c   Banas, Tomasz ^a   Bednarek, Wieslawa ^c   Obrzut, Bogdan ^d   Blecharz, Pawel ^a   Reron, Alfred ^a   Kalinka, Jaroslaw ^e  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d UNIVERSITY OF RZESZÓW   (Poland)

^e MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Decidua; Immune cells; RCAS1; Stillbirth

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; FETAL ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; OXYTOCIN; PROSTAGLANDIN DERIVATIVE; RCAS1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FETUS DEATH; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABOR INDUCTION; LABOR ONSET; MOLECULAR DYNAMICS; PRIORITY JOURNAL; STILLBIRTH;

ADULT; ANTIGENS, NEOPLASM; CELLS, CULTURED; DECIDUA; FEMALE; FETAL DEATH; FETAL DISEASES; HUMANS; OXYTOCIN; PREGNANCY; PROSTAGLANDINS; STILLBIRTH;

EID: 56149098743     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00648.x     Document Type: Article

References (54)

1. Smith GC, Fretts RC: Stillbirth. Lancet 2007; 370:1715-1725.
2. McClure EM, Goldenberg RL, Bann CM: Maternal mortality, stillbirth and measures of obstetric care in developing and developed countries. Int J Gynaecol Obstet 2007; 96:139-146.
3. Stanton C, Lawn JE, Rahman H, Wilczynska-Ketende K, Hill K: Stillbirth rates: Delivering estimates in 190 countries. Lancet 2006; 367:1487-1494.
4. Goldenberg RL, McClure EM, Bann CM: The relationship of intrapartum and antepartum stillbirth rates to measures of obstetric care in developed and developing countries. Acta Obstet Gynecol Scand 2007; 86:1303-1309.
5. Wicherek L: The role of the endometrium in the regulation of immune cell activity. Front Biosci 2008; 13:1018-1035.
6. Wu WX, Zhang Q, Ma XH, Unno N, Nathanielsz PW: Suppression subtractive hybridization identified a marked increase in thrombospondin-1 associated with parturition in pregnant sheep myometrium. Endocrinology 1999; 140:2364-2371.
7. Beshay VE, Carr BR, Rainey WE: The human fetal adrenal gland, corticotropin-releasing hormone, and parturition. Semin Reprod Med 2007; 25:14-20.
8. Smith R, Nicholson RC: Corticotrophin releasing hormone and the timing of birth. Front Biosci 2007; 12:912-918.
9. Mastorakos G, Ilias I: Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann NY Acad Sci 2003; 997:136-149.
10. Terzidou V, Sooranna SR, Kim LU, Thornton S, Bennett PR, Johnson MR: Mechanical stretch up-regulates the human oxytocin receptor in primary human uterine myocytes. J Clin Endocrinol Metab 2005; 90:237-246.
11. Mohan AR, Sooranna SR, Lindstrom TM, Johnson MR, Bennett PR: The effect of mechanical stretch on cyclo-oxygenase type 2 expression and activator protein-1 and nuclear factor-kappaB activity in human amnion cells. Endocrinology 2007; 148:1850-1857.
12. Osman I, Young A, Jordan F, Greer IA, Norman JE: Leukocyte density and proinflammatory mediator expression in regional human fetal membranes and decidua before and during labor at term. J Soc Gynecol Investig 2006; 13:97-103.
13. Loudon JA, Elliott CL, Hills F, Bennett PR: Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells. Biol Reprod 2003; 69:331-337.
14. Friebe-Hoffmann U, Baston DM, Hoffmann TK, Chiao JP, Rauk PN: The influence of interleukin-1beta on oxytocin signalling in primary cells of human decidua. Regul Pept 2007; 142:78-85.
15. Mitchell MD, Edwin S, Romero RJ: Prostaglandin biosynthesis by human decidual cells: Effects of inflammatory mediators. Prostaglandins Leukot Essent Fatty Acids 1990; 41:35-38.
16. Mitchell MD, Simpson KL, Keelan JA: Paradoxical proinflammatory actions of interleukin-10 in human amnion: Potential roles in term and preterm labour. J Clin Endocrinol Metab 2004; 89:4149-4152.
17. Furuta I, Yamada H, Sagawa T, Fujimoto S: Effects of inflammatory cytokines on prostaglandin E(2) production from human amnion cells cultured in serum-free condition. Gynecol Obstet Invest 2000; 49:93-97.
18. Al-Asmakh M, Race H, Tan S, Sullivan MH: The effects of oxygen concentration on in vitro output of prostaglandin E2 and interleukin-6 from human fetal membranes. Mol Hum Reprod 2007; 13:197-201.
19. Helliwell RJ, Keelan JA, Marvin KW, Adams L, Chang MC, Anand A, Sato TA, O'Carroll S, Chaiworapongsa T, Romero RJ, Mitchell MD: Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived anti-inflammatory prostaglandins in human placenta. J Clin Endocrinol Metab 2006; 9:597-606.
20. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD: Cytokines, prostaglandins and parturition-a review. Palcenta 2003; 24 (Suppl. A) S33-S46.
21. Szekeres-Bartho J, Varga P, Pacsa AS: Immunologic factors contributing to the initiation of labor-lymphocyte reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol 1986; 155:108-112.
22. Abadia-Molina AC, Ruiz C, Montes MJ, King A, Loke YW, Olivares EG: Immune phenotype and cytotoxic activity of lymphocytes from human term decidua against trophoblast. J Reprod Immunol 1996; 31:109-123.
23. Sindram-Trujillo AP, Scherjon SA, van Hulst-van Miert PP, Kanhai HH, Roelen DL, Claas FH: Comparison of decidual leukocytes following spontaneous vaginal delivery and elective cesarean section in uncomplicated human term pregnancy. J Reprod Immunol 2004; 62:125-137.
24. Olson DM, Ammann C: Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci 2007; 12:1329-1343.
25. Ugur Y, Cakar AN, Beksac MS, Dagdeviren A: Activation antigens during the proliferative and secretory phases of endometrium and early-pregnancy decidua. Gynecol Obstet Invest 2006; 62:66-74.
26. Wicherek L, Galazka K: The possible correlation between the patient's immune tolerance level during cesarean section and the incidence of subsequent emergency peripartum hysterectomy. Clin Dev Immunol 2007; 2007:63596 (doi: 10.1155/2007/63596).
27. Steinborn A, Sohn C, Sayehli C, Baudendistel A, Huwelmeier D, Solbach C, Schmitt E, Kaufmann M: Spontaneous labor at term is associated with fetal monocyte activation. Clin Exp Immunol 1999; 117:147-152.
28. Wicherek L, Klimek M, Czekierdowski A, Popiela TJ, Galazka K, Dutsch-Wicherek M: The placental RCAS1 expression during stillbirth. Reprod Biol Endocrinol 2005; 3:24.
29. Wicherek L, Basta P, Galazka K, Mak P, Dancewicz L, Kalinka J: RCAS1 decidual immunoreactivity and RCAS1 serum level during cesarean section with respect to the progression of labor. Am J Reprod Immunol 2008; 59:152-158.
30. Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M: The role of RCAS1 and oxytocinase in immune tolerance during pregnancy. Fetal Diagn Ther 2005; 20:420-425.
31. Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K: Relationship between human tumor-associated antigen RCAS1 and gestational diabetes mellitus. Am J Reprod Immunol 2007; 58:440-446.
32. Wicherek L, Galazka K, Lazar A: RCAS1 decidual immunoreactivity during placental abruption: Immune cell presence and activity. Am J Reprod Immunol 2007; 58:46-55.
33. Wicherek L, Basta P, Sikora J, Galazka K, Rytlewski K, Grabiec M, Lazar A, Kalinka J: RCAS1 decidual immunoreactivity in severe pre-eclampsia: immune cell presence and activity. Am J Reprod Immunol 2007; 58:358-366.
34. Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K: The human tumor-associated antigen RCAS1 in pregnancies complicated by preeclampsia. J Reprod Immunol 2008; 77:100-108.
35. Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5:938-942.
36. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol 2005; 97:772-779.
37. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Invasive potency related to RCAS1 expression in uterine cervical cancer. Gynecol Oncol 2005; 99:189-198.
38. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Clinical significance of RCAS1 as a biomarker of uterine cancer. Gynecol Oncol 2006; 103:924-931.
39. Sonoda K, Miyamoto S, Nakashima M, Wake N: The biological role of the unique molecule RCAS1: A bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front Biosci 2008; 13:1106-1116.
40. Sonoda K, Nakashima M, Saito T, Amada S, Kamura T, Nalano H, Watanabe T: Establishment of a new human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anti-cancer reagents. Int J Oncol 1995; 6:1099-1104.
41. Sonoda K, Miyamoto S, Hirakawa T, Kaku T, Nakashima M, Watanabe T, Akazawa K, Fujita T, Nakano H: Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. Br J Cancer 2003; 89:546-551.
42. Dutsch-Wicherek M, Wicherek L: The association of RCAS1 serum concentration with the reversibility or irreversibility of the process of immune cytotoxic activity restriction during normal menstrual cycle, cancer relapse, and surgical treatment for various types of squamous cell carcinomas and adenocarcinomas. Am J Reprod Immunol 2008; 59:266-275.
43. Matsushima T, Nakashima M, Oshima K, Abe Y, Nishimura J, Nawata H, Watanabe T, Muta K: Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 2001; 98:313-321.
44. Han Y, Qin W, Huang G: Knockdown of RCAS1 expression by RNA interference recovers T cell growth and proliferation. Caner Lett 2007; 257:182-190.
45. Skret-Magierlo J, Wicherek L, Basta P, Galazka K, Sikora J, Wilk M, Fudali L, Skret A: RCAS1 decidual immunoreactivity during cesarean section in scar deciduosis: Immune cell presence and activity. Gynecol Obstet Invest 2007; 65:187-194.
46. Weiss A, Goldman S, Shalev E: The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci 2007; 12:649-659.
47. Vargas ML, Santos JL, Ruiz C, Montes MJ, Aleman P, Garcia-Tortosa C, Garcia-Olivares E: Comparison of the proportions of leukocytes in early and term human decidua. Am J Reprod Immunol 1993; 29:135-140.
48. Watanabe M, Iwatani Y, Kaneda T, Hidaka Y, Mitsuda N, Morimoto Y, Amino N: Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Jmmunol 1997; 37:368-377.
49. Sooranna SR, Grigsby PL, Engineer N, Liang Z, Sun K, Myatt L, Johnson MR: Myometrial prostaglandin E2 synthetic enzyme mRNA expression: spatial and temporal variations with pregnancy and labour. Mol Hum Reprod 2006; 12:625-631.
50. Waldorf KM, Persing D, Novy MJ, Sadowsky DW, Gravett MG: Pretreatment with toll-like receptor 4 antagonist inhibits lipopolysaccharide-induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reprod Sci 2008; 15:121-127.
51. Lappas M, Permezel M, Holdsworth SJ, Zanoni G, Porta A, Rice GE: Antiinflammatory effects of the cyclopentenone isoprostane 15-A(2)-IsoP in human gestational tissues. Free Radic Biol Med 2007; 42:1791-1796.
52. Keelan JA, Sato TA, Gupta DK, Marvin KW, Mitchell MD: Prostanoid stimulation of cytokine production in an amnion-derived cell line: evidence of a feed-forward mechanism with implications for term and preterm labor. J Soc Gynecol Investig 2000; 7:37-44.
53. Kelly RW: Inflammatory mediators and cervical ripening. J Reprod Immunol 2002; 57:217-224.
54. Meadows JW, Eis AL, Brockman DE, Myatt L: Expression and localization of prostaglandin E synthase isoforms in human fetal membranes in term and preterm labor. J Clin Endocrinol Metab 2003; 88:433-439.